34221-61-9 Usage
Uses
Used in Organic Synthesis:
FLUOREN-9-YL-METHYLAMINE HYDROCHLORIDE is used as a reagent or intermediate in the synthesis of pharmaceuticals, agrochemicals, and materials. Its unique structure allows it to be a valuable component in creating a variety of complex organic compounds.
Used in Research and Development:
In the realm of research and development, FLUOREN-9-YL-METHYLAMINE HYDROCHLORIDE serves as a building block for constructing more intricate chemical structures. Its properties make it a useful tool for advancing scientific understanding and developing new technologies.
Used in Medicine and Biotechnology:
Due to its distinctive chemical characteristics, FLUOREN-9-YL-METHYLAMINE HYDROCHLORIDE has potential applications in medicine and biotechnology. Its specific uses in these fields, however, would depend on further research and development to harness its properties effectively.
Check Digit Verification of cas no
The CAS Registry Mumber 34221-61-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,4,2,2 and 1 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 34221-61:
(7*3)+(6*4)+(5*2)+(4*2)+(3*1)+(2*6)+(1*1)=79
79 % 10 = 9
So 34221-61-9 is a valid CAS Registry Number.
34221-61-9Relevant articles and documents
Anti-viral method
-
, (2008/06/13)
PCT No. PCT/US97/07431 Sec. 371 Date Jan. 6, 1999 Sec. 102(e) Date Jan. 6, 1999 PCT Filed May 2, 1997 PCT Pub. No. WO97/41846 PCT Pub. Date Nov. 13, 1997The present invention provides compounds which inhibit an envelope virus by inhibiting the fusion of the virus with the host cell. The virus may be inhibited in an infected cell, a cell susceptible of infection or a mammal in need thereof.
Urea, thiourea and guanidine compounds and their use as anti-viral agents
-
, (2008/06/13)
The present invention provides compounds which inhibit an envelope virus by inhibiting the fusion of the virus with the host cell. The virus may be inhibited in an infected cell, a cell susceptible of infection or a mammal in need thereof.